{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:14:30Z","timestamp":1789582470531,"version":"build-2803163510"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cca.2025.120580","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T14:50:39Z","timestamp":1756565439000},"page":"120580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Neurofilament light chain in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"578","author":[{"given":"Neeraj Kumar","family":"Fuloria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendran","family":"Sekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omji","family":"Porwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Tahir","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Narain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangita","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumita","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unnikrishnan Meenakshi","family":"Dhanalekshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivkanya","family":"Fuloria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2025.120580_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102481","article-title":"Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: breaking the memory barrier","volume":"101","author":"Kamatham","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.cca.2025.120580_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1601712","article-title":"Unveiling the therapeutic potential of natural products in Alzheimer's disease: insights from in vitro, in vivo, and clinical studies","volume":"16","author":"Aktary","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cca.2025.120580_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2024.101009","article-title":"Fluid biomarkers in multiple sclerosis: from current to future applications","volume":"44","author":"Di Filippo","year":"2024","journal-title":"The Lancet Regional Health. Europe"},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12987-022-00403-2","article-title":"Elevated neurofilament light chain CSF\/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension","volume":"20","author":"Engel","year":"2023","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/acs.chemrev.8b00257","article-title":"Highly sensitive and multiplexed protein measurements","volume":"119","author":"Cohen","year":"2019","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12936-020-03225-5","article-title":"Comparison of ELISA with electro-chemiluminescence technology for the qualitative and quantitative assessment of serological responses to vaccination","volume":"19","author":"Bolton","year":"2020","journal-title":"Malar. J."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0035","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12035-019-01698-3","article-title":"Neurofilament light chain as a biomarker, and correlation with magnetic resonance imaging in diagnosis of CNS-related disorders","volume":"57","author":"Alirezaei","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.cca.2025.120580_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10051045","article-title":"Cerebrospinal fluid neurofilament light predicts risk of dementia onset in cognitively healthy individuals and rate of cognitive decline in mild cognitive impairment: a prospective longitudinal study","volume":"10","author":"Dhiman","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0045","article-title":"Neurofilament light chain levels are predictive of clinical conversion in radiologically isolated syndrome","volume":"10","author":"Rival","year":"2023","journal-title":"Neurology(r) Neuroimmunology & Neuroinflammation"},{"issue":"4","key":"10.1016\/j.cca.2025.120580_b0050","article-title":"Exploring the clinical utility of neurofilament light chain assays in multiple sclerosis management","volume":"12","author":"Bar-Or","year":"2025","journal-title":"Neurology(r) Neuroimmunology & Neuroinflammation"},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13195-017-0331-1","article-title":"The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias","volume":"10","author":"Abu-Rumeileh","year":"2018","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0060","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1038\/s41598-023-29704-8","article-title":"Neurofilament-light chain quantification by Simoa and Ella in plasma from patients with dementia: a comparative study","volume":"13","author":"Truffi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120580_b0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neurobiolaging.2020.07.018","article-title":"Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer\u2019s disease","volume":"95","author":"Andersson","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"7","key":"10.1016\/j.cca.2025.120580_b0070","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jim.2013.11.008","article-title":"The impact of pre-analytical variables on the stability of neurofilament proteins in CSF, determined by a novel validated SinglePlex Luminex assay and ELISA","volume":"402","author":"Koel-Simmelink","year":"2014","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0080","doi-asserted-by":"crossref","first-page":"19982","DOI":"10.1038\/s41598-020-77098-8","article-title":"Serum neurofilament light chain withstands delayed freezing and repeated thawing","volume":"10","author":"Altmann","year":"2020","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.cca.2025.120580_b0085","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum","volume":"78","author":"Benedet","year":"2021","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13195-018-0339-1","article-title":"A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation","volume":"10","author":"Gaetani","year":"2018","journal-title":"Alzheimers Res. Ther."},{"issue":"10","key":"10.1016\/j.cca.2025.120580_b0095","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","article-title":"Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa","volume":"54","author":"Kuhle","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2021-000143","article-title":"Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis","volume":"3","author":"Alagaratnam","year":"2021","journal-title":"BMJ Neurol. Open"},{"issue":"15","key":"10.1016\/j.cca.2025.120580_b0105","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.4155\/bio-2019-0163","article-title":"Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood","volume":"11","author":"Hendricks","year":"2019","journal-title":"Bioanalysis"},{"issue":"11","key":"10.1016\/j.cca.2025.120580_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8110523","article-title":"Blood neurofilament light chain: the neurologist's troponin?","volume":"8","author":"Thebault","year":"2020","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.cca.2025.120580_b0115","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nbt.1641","article-title":"Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations","volume":"28","author":"Rissin","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cca.2025.120580_b0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ebiom.2015.11.036","article-title":"Plasma Concentration of the neurofilament light protein (NFL) is a biomarker of CNS Injury in HIV infection: a cross-sectional study","volume":"3","author":"Gissl\u00e9n","year":"2016","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.cca.2025.120580_b0125","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.cca.2025.120580_b0130","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/brain\/awy154","article-title":"Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis","volume":"141","author":"Barro","year":"2018","journal-title":"Brain J. Neurol."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2016.05.018","article-title":"Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases","volume":"91","author":"Bacioglu","year":"2016","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.cca.2025.120580_b0140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-018-0404-9","article-title":"Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease","volume":"10","author":"Lewczuk","year":"2018","journal-title":"Alzheimers Res. Ther."},{"issue":"5","key":"10.1016\/j.cca.2025.120580_b0150","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/1352458518765666","article-title":"Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis","volume":"25","author":"Siller","year":"2019","journal-title":"Multiple Sclerosis (Houndmills, Basingstoke, England)"},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0155","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13195-024-01647-w","article-title":"Blood-based biomarkers and plasma A\u03b2 assays in the differential diagnosis of Alzheimer's disease and behavioural-variant frontotemporal dementia","volume":"16","author":"Mohaupt","year":"2024","journal-title":"Alzheimers Res. Ther."},{"issue":"5","key":"10.1016\/j.cca.2025.120580_b0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders - towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.cca.2025.120580_b0165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12014-020-09296-5","article-title":"Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis","volume":"17","author":"Guldbrandsen","year":"2020","journal-title":"Clin. Proteomics"},{"issue":"2","key":"10.1016\/j.cca.2025.120580_b0170","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac045","article-title":"A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer's disease","volume":"4","author":"Budelier","year":"2022","journal-title":"Brain Commun."},{"issue":"4","key":"10.1016\/j.cca.2025.120580_b0175","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae247","article-title":"Multi-peptide characterization of plasma neurofilament light chain in preclinical and mild Alzheimer's disease","volume":"6","author":"Coulton","year":"2024","journal-title":"Brain Commun."},{"issue":"3","key":"10.1016\/j.cca.2025.120580_b0180","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae132","article-title":"CSF neurofilament light chain profiling and quantitation in neurological diseases","volume":"6","author":"Leckey","year":"2024","journal-title":"Brain Commun."},{"issue":"2","key":"10.1016\/j.cca.2025.120580_b0185","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaf129","article-title":"Novel insights into the molecular nature of neurofilament light polypeptide species in cerebrospinal fluid","volume":"7","author":"Becker","year":"2025","journal-title":"Brain Commun."},{"issue":"2","key":"10.1016\/j.cca.2025.120580_b0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/acschemneuro.4c00526","article-title":"Neurofilament light chain under the lens of structural mass spectrometry","volume":"16","author":"Coppens","year":"2025","journal-title":"ACS Chem. Nerosci."},{"issue":"8","key":"10.1016\/j.cca.2025.120580_b0195","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cca.2025.120580_b0200","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.dadm.2018.06.001","article-title":"Stability of blood-based biomarkers of Alzheimer's disease over multiple freeze-thaw cycles","volume":"10","author":"Keshavan","year":"2018","journal-title":"Alzheimer's & Dementia (Amsterdam, Netherlands)"},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0205","article-title":"Effects of pre-analytical procedures on blood biomarkers for Alzheimer's pathophysiology, glial activation, and neurodegeneration","volume":"13","author":"Ashton","year":"2021","journal-title":"Alzheimer's & Dementia (Amsterdam Netherlands)"},{"key":"10.1016\/j.cca.2025.120580_b0210","doi-asserted-by":"crossref","unstructured":"Z. van Lierop, I.M.W. Verberk, K.W.J. van Uffelen, M.J.A. Koel-Simmelink, L. In 't Veld, J. Killestein, C.E. Teunissen, Pre-analytical stability of serum biomarkers forneurological disease: neurofilament-light, glial fibrillary acidic protein and contactin-1, Clinical chemistry and laboratory medicine 60(6) (2022) 842-850.","DOI":"10.1515\/cclm-2022-0007"},{"issue":"8","key":"10.1016\/j.cca.2025.120580_b0215","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/alz.12510","article-title":"Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group","volume":"18","author":"Verberk","year":"2022","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.cca.2025.120580_b0220","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3233\/JAD-230384","article-title":"Pre-analytical variables influencing stability of blood-based biomarkers of neuropathology","volume":"95","author":"Panikkar","year":"2023","journal-title":"J. Alzheimer's Disease: JAD"},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0225","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/jnc.15757","article-title":"Impact of pre-analytical sample handling factors on plasma biomarkers of Alzheimer's disease","volume":"165","author":"Kurz","year":"2023","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.cca.2025.120580_b0230","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1111\/jnc.16130","article-title":"Effect of blood collection tube containing protease inhibitors on the pre-analytical stability of Alzheimer's disease plasma biomarkers","volume":"168","author":"Chen","year":"2024","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.cca.2025.120580_b0235","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3233\/JAD-190615","article-title":"Neurofilament light chain in cerebrospinal fluid and blood as a biomarker for neurodegenerative diseases: a systematic review and meta-analysis","volume":"72","author":"Wang","year":"2019","journal-title":"J. Alzheimer's Disease : JAD"},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0240","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","article-title":"A multicentre validation study of the diagnostic value of plasma neurofilament light","volume":"12","author":"Ashton","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0245","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3233\/ADR-230045","article-title":"Prognostic and predictive factors in early Alzheimer's disease: a systematic review","volume":"8","author":"Garcia","year":"2024","journal-title":"J. Alzheimer's Disease Rep."},{"key":"10.1016\/j.cca.2025.120580_b0250","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13024-015-0059-y","article-title":"Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay","volume":"10","author":"Heywood","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cca.2025.120580_b0255","unstructured":"J. Ask, Cerebrospinal fluid neurofilament light chain as a biomarker in neuroaxonal damage: Comparing and analysing quantification with two analytical assays, (2020)."},{"issue":"6","key":"10.1016\/j.cca.2025.120580_b0260","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/jalm\/jfae099","article-title":"Comparison of a fully automated platform and an established ELISA for the quantification of neurofilament light chain in patients with cognitive decline","volume":"9","author":"Agnello","year":"2024","journal-title":"J. Appl. Lab. Med."},{"issue":"14","key":"10.1016\/j.cca.2025.120580_b0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411624","article-title":"Neurofilament-light, a promising biomarker: analytical, metrological and clinical challenges","volume":"24","author":"Coppens","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2025.120580_b0270","doi-asserted-by":"crossref","unstructured":"C. Delaby, A. Ladang, J. Martinez-Yriarte, C. Zecca, G. Logroscino, P. K\u00f6rtvelyessy, H. Tumani, P. Parchi, I. Quadrio, M. Hart, D.A. Olsen, D. Alcolea, K. Blennow, J. Fortea, A. Lleo, A. Algeciras-Schimnich, X. Ayrignac, A. Bedel, G.A.A. Santos, W. Borelli, E. Bouaziz-Amar, I. Baldeiras, E. Bigot-Corbel, M. Bjerke, M. Carretero Perez, T. Casoli, T. Chabrashvili, M.D. Chapman, J. Cusato, E. Dursun, A. Fourier, D. Galimberti, D. Gezen-Ak, B.A. Gordon, J. Gouju, S. de Las Heras Florez, J. Hernandez Sanchez, M. Herwerth, D. Imperiale, F. Kaczorowski, K. Kasuga, A. Keshavan, M. Khalil, J. Kuhle, C. Leithner, P. Lewczuk, F. Letournel, M. Tsolaki, G.M. Giuffr\u00e8, M.C. Blanc, B. Mroczko, J.E. Mart\u00ednez Rodr\u00edguez, G. Musso, A. Kulczynska-Przybik, L. Nogueira, C. Paquet, S. Baiardi, L. Gaetani, L. Parnetti, R. Perez Garay, K. Poesen, M. Quillard-Muraine, E. Rodriguez Borja, S. Schraen, D. Terracciano, F. Bachhuber, S. Halbgebauer, S. Tzartos, J. Tzartos, N. Unterwalder, L. Vermunt, C.L. Wellington, H. Zetterberg, C. Teunissen, S. Lehmann, Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview, Alzheimer's & dementia : the journal of the Alzheimer's Association 21(6) (2025) e70343.","DOI":"10.2139\/ssrn.5142806"},{"issue":"15","key":"10.1016\/j.cca.2025.120580_b0275","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161415","article-title":"Enhancing the clinical value of serum neurofilament light chain measurement","volume":"7","author":"Kosa","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.cca.2025.120580_b0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12014-020-09285-8","article-title":"Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer's disease","volume":"17","author":"Zhou","year":"2020","journal-title":"Clin. Proteomics"},{"issue":"4","key":"10.1016\/j.cca.2025.120580_b0285","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.25152","article-title":"Establishing decisional cutoff values of neurofilament light chains in cerebrospinal fluid measured by fully automated chemiluminescent enzyme immunoassay","volume":"39","author":"Agnello","year":"2025","journal-title":"J. Clin. Lab. Anal."},{"issue":"4","key":"10.1016\/j.cca.2025.120580_b0290","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/jnc.14635","article-title":"Mass spectrometry: a platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases","volume":"151","author":"Cilento","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cca.2025.120580_b0295","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.935382","article-title":"Development of a highly sensitive neurofilament light chain assay on an automated immunoassay platform","volume":"13","author":"Lee","year":"2022","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0300","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-023-02660-3","article-title":"Optimal blood tau species for the detection of Alzheimer's disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study","volume":"147","author":"Montoliu-Gaya","year":"2023","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.cca.2025.120580_b0305","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11051250","article-title":"Discovery of biomarkers for amyotrophic lateral sclerosis from human cerebrospinal fluid using mass-spectrometry-based proteomics","volume":"11","author":"Oh","year":"2023","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.cca.2025.120580_b0310","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14621","article-title":"Biomarker discovery in Alzheimer's and neurodegenerative diseases using Nucleic Acid Linked Immuno-Sandwich Assay","volume":"21","author":"Ashton","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0315","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1038\/s41467-024-52937-8","article-title":"Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer's disease","volume":"15","author":"Hofmann","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2025.120580_b0320","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neurobiolaging.2021.07.013","article-title":"CSF neurofilament light may predict progression from amnestic mild cognitive impairment to Alzheimer's disease dementia","volume":"107","author":"Lim","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cca.2025.120580_b0325","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2020.05.011","article-title":"A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's disease","volume":"94","author":"Sugarman","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0330","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16089","article-title":"Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: a cross-sectional and longitudinal study","volume":"31","author":"Mazzeo","year":"2024","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0335","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13195-024-01593-7","article-title":"Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study","volume":"16","author":"G\u00f6tze","year":"2024","journal-title":"Alzheimers Res. Ther."},{"issue":"24","key":"10.1016\/j.cca.2025.120580_b0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417361","article-title":"Blood neurofilament levels predict cognitive decline across the Alzheimer's disease continuum","volume":"24","author":"Lehmann","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.cca.2025.120580_b0345","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","article-title":"Plasma neurofilament light chain as a biomarker of Alzheimer's disease in subjective cognitive decline and mild cognitive impairment","volume":"269","author":"Giacomucci","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.cca.2025.120580_b0350","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2023.1284416","article-title":"Serum neurofilament light chain levels in patients with cognitive deficits and movement disorders: comparison of cerebrospinal and serum neurofilament light chain levels with other biomarkers","volume":"17","author":"Novobilsk\u00fd","year":"2023","journal-title":"Front. Hum. Neurosci."},{"issue":"7","key":"10.1016\/j.cca.2025.120580_b0355","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"The Lancet. Neurol."},{"issue":"9","key":"10.1016\/j.cca.2025.120580_b0360","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/jnnp-2018-319784","article-title":"Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia","volume":"90","author":"Meeter","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.cca.2025.120580_b0365","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"The Lancet. Neurol."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0370","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13195-021-00805-8","article-title":"Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression","volume":"13","author":"Clark","year":"2021","journal-title":"Alzheimers Res. Ther."},{"issue":"3","key":"10.1016\/j.cca.2025.120580_b0375","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00415-023-12066-6","article-title":"Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study","volume":"271","author":"Vrillon","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.cca.2025.120580_b0380","article-title":"Novel biomarkers for Alzheimer's disease: plasma neurofilament light and cerebrospinal fluid","volume":"2024","author":"Abukuri","year":"2024","journal-title":"Int. J. Alzheimers Dis."},{"issue":"17","key":"10.1016\/j.cca.2025.120580_b0385","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.18632\/aging.102220","article-title":"Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults","volume":"11","author":"Hu","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.cca.2025.120580_b0390","article-title":"Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease","volume":"12","author":"Dhiman","year":"2020","journal-title":"Alzheimer's & Dementia (Amsterdam Netherlands)"},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0395","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13195-021-00953-x","article-title":"Serum neurofilament light chain level as a predictor of cognitive stage transition","volume":"14","author":"Lee","year":"2022","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0400","doi-asserted-by":"crossref","first-page":"11307","DOI":"10.1038\/s41598-024-61655-6","article-title":"Future perspective and clinical applicability of the combined use of plasma phosphorylated tau 181 and neurofilament light chain in Subjective Cognitive Decline and Mild Cognitive Impairment","volume":"14","author":"Giacomucci","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120580_b0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106267","article-title":"Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia","volume":"186","author":"Giuffr\u00e8","year":"2023","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0410","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/brain\/awad267","article-title":"The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease","volume":"147","author":"Jung","year":"2024","journal-title":"Brain J. Neurol."},{"issue":"9","key":"10.1016\/j.cca.2025.120580_b0415","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/jnnp-2020-323487","article-title":"Diagnostic and prognostic value of serum NfL and p-Tau(181) in frontotemporal lobar degeneration","volume":"91","author":"Benussi","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.cca.2025.120580_b0420","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3233\/JAD-200011","article-title":"Plasma neurofilament Light: a Marker of neurodegeneration in mild behavioral impairment","volume":"76","author":"Naude","year":"2020","journal-title":"J. Alzheimer's Disease: JAD"},{"issue":"4","key":"10.1016\/j.cca.2025.120580_b0425","article-title":"Neurofilament light chain levels in serum among a large mixed memory clinic cohort: Confounders and diagnostic usefulness","volume":"15","author":"Simonsen","year":"2023","journal-title":"Alzheimer's & Dementia (amsterdam, Netherlands)"},{"issue":"7","key":"10.1016\/j.cca.2025.120580_b0430","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaneurol.2025.1100","article-title":"Evaluation of the revised criteria for biological and clinical staging of Alzheimer Disease","volume":"82","author":"Pichet Binette","year":"2025","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.cca.2025.120580_b0435","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13910","article-title":"Clinical usefulness of cerebrospinal fluid biomarkers in Alzheimer's disease","volume":"53","author":"Pe\u00f1a-Bautista","year":"2023","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0440","doi-asserted-by":"crossref","DOI":"10.1093\/cercor\/bhad405","article-title":"Serum biomarkers and disease progression in CT-negative mild traumatic brain injury","volume":"34","author":"Jia","year":"2024","journal-title":"Cerebral Cortex (New York, N.Y.)"},{"issue":"7","key":"10.1016\/j.cca.2025.120580_b0445","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1515\/cclm-2023-0036","article-title":"Neurofilament light chain as neuronal injury marker- what is needed to facilitate implementation in clinical laboratory practice?","volume":"61","author":"Arslan","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"issue":"4","key":"10.1016\/j.cca.2025.120580_b0450","doi-asserted-by":"crossref","first-page":"256","DOI":"10.14283\/jpad.2020.6","article-title":"PTI-125 reduces biomarkers of Alzheimer's disease in patients","volume":"7","author":"Wang","year":"2020","journal-title":"J. Prev Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0455","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jnnp-2021-327129","article-title":"Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS","volume":"93","author":"Halbgebauer","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.cca.2025.120580_b0460","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jalz.2017.11.015","article-title":"Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: A\u03b2(1-42), total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40","volume":"14","author":"Hampel","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"s1","key":"10.1016\/j.cca.2025.120580_b0465","doi-asserted-by":"crossref","first-page":"S271","DOI":"10.3233\/JAD-179926","article-title":"From cerebrospinal fluid to blood: the third wave of fluid biomarkers for Alzheimer's disease","volume":"64","author":"Zetterberg","year":"2018","journal-title":"J. Alzheimer's Disease: JAD"},{"key":"10.1016\/j.cca.2025.120580_b0470","doi-asserted-by":"crossref","unstructured":"J.D. Doecke, G. Bellomo, L. Vermunt, D. Alcolea, S. Halbgebauer, S. In 't Veld, N. Mattsson-Carlgren, K. Veverova, C.J. Fowler, L. Boonkamp, I.M. Houtkamp, M. Koel-Simmerlink, I.M.W. Verberk, L. Gaetani, A. Toja, A.L. Wojda\u0142a, J. Fortea, Y. Pijnenburg, A. Lemstra, W. van der Flier, J. Hort, M. Otto, O. Hansson, L. Parnetti, C.L. Masters, A. Lle\u00f3, A. Gonz\u00e1lez-Escalante, J. Contador, M. Su\u00e1rez-Calvet, A. Fern\u00e1ndez-Lebrero, A. Puig-Pijoan, P. Ortiz-Romero, E. Jim\u00e9nez-Moyano, C. Minguill\u00f3n, M. Del Campo, C. Teunissen, Diagnostic performance of plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study, Alzheimer's & dementia : the journal of the Alzheimer's Association 21(6) (2025) e14573.","DOI":"10.1002\/alz.14573"},{"key":"10.1016\/j.cca.2025.120580_b0475","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.749649","article-title":"Performance of plasma amyloid \u03b2 total tau, and neurofilament light chain in the identification of probable Alzheimer's disease in South China","volume":"13","author":"Jiao","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0480","article-title":"Clinical and neuropathological associations of plasma A\u03b2(42)\/A\u03b2(40), p-tau217 and neurofilament light in sporadic frontotemporal dementia spectrum disorders","volume":"17","author":"Rajbanshi","year":"2025","journal-title":"Alzheimer's & Dementia (Amsterdam, Netherlands)"},{"issue":"1","key":"10.1016\/j.cca.2025.120580_b0485","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13195-024-01526-4","article-title":"Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression","volume":"16","author":"Rabl","year":"2024","journal-title":"Alzheimers Res. Ther."},{"issue":"14","key":"10.1016\/j.cca.2025.120580_b0490","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.2174\/1381612828666220413094918","article-title":"Neuroproteomics chip-based mass spectrometry and other techniques for Alzheimer's disease biomarkers - update","volume":"28","author":"Pomilio","year":"2022","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.cca.2025.120580_b0495","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3233\/JAD-200022","article-title":"Plasma neurofilament light and longitudinal progression of white matter hyperintensity in elderly persons without dementia","volume":"75","author":"Sun","year":"2020","journal-title":"J. Alzheimer's Disease: JAD"},{"issue":"10","key":"10.1016\/j.cca.2025.120580_b0500","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.15252\/emmm.201606540","article-title":"Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease","volume":"8","author":"Mattsson","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"6","key":"10.1016\/j.cca.2025.120580_b0505","doi-asserted-by":"crossref","first-page":"e9356","DOI":"10.15252\/msb.20199356","article-title":"Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease","volume":"16","author":"Bader","year":"2020","journal-title":"Mol. Syst. Biol."},{"issue":"8","key":"10.1016\/j.cca.2025.120580_b0510","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(21)00129-0","article-title":"Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with down syndrome: a cohort study","volume":"20","author":"Carmona-Iragui","year":"2021","journal-title":"The Lancet. Neurol."},{"key":"10.1016\/j.cca.2025.120580_b0515","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2022-329020","article-title":"Serum neurofilament light chain levels predict long-term disability progression in patients with progressive multiple sclerosis","author":"Comabella","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cca.2025.120580_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123115","article-title":"Clinical utility of the Lumipulse\u2122 immunoassay for plasma neurofilament light chain in multiple sclerosis","volume":"463","author":"Nicolella","year":"2024","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.cca.2025.120580_b0525","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1007\/s10072-025-08023-y","article-title":"Advances in biomarker discovery and diagnostics for Alzheimer \u2019s disease","volume":"46","author":"Bhatia","year":"2025","journal-title":"Neurol. Sci."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125004590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125004590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T13:08:49Z","timestamp":1763039329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125004590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":105,"alternative-id":["S0009898125004590"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120580","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofilament light chain in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120580"}}